Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India

J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1060-1068. doi: 10.1016/j.jmii.2022.06.001. Epub 2022 Jul 2.

Abstract

Background: During October 2020, Delta variant was detected for the first time in India and rampantly spread across the globe. It also led to second wave of pandemic in India which affected millions of people. However, there is limited information pertaining to the SARS-CoV-2 strain infecting the children in India.

Methods: Here, we assessed the SARS-CoV-2 lineages circulating in the pediatric population of India during the second wave of the pandemic. Clinical and demographic details linked with the nasopharyngeal/oropharyngeal swabs (NPS/OPS) collected from SARS-CoV-2 cases (n = 583) aged 0-18 year and tested positive by real-time RT-PCR were retrieved from March to June 2021.

Results: Symptoms were reported among 37.2% of patients and 14.8% reported to be hospitalized. The E gene CT value had significant statistical difference at the point of sample collection when compared to that observed in the sequencing laboratory. Out of these 512 sequences 372 were VOCs, 51 were VOIs. Most common lineages observed were Delta, followed by Kappa, Alpha and B.1.36, seen in 65.82%, 9.96%, 6.83% and 4.68%, respectively in the study population.

Conclusion: Overall, it was observed that Delta strain was the leading cause of SARS-CoV-2 infection in Indian children during the second wave of the pandemic. We emphasize on the need of continuous genomic surveillance in SARS-CoV-2 infection even amongst children.

Keywords: COVID-19; Delta variant; India; Pediatric; SARS-CoV-2.

MeSH terms

  • Asian People
  • COVID-19* / epidemiology
  • Child
  • Humans
  • India / epidemiology
  • SARS-CoV-2 / genetics

Supplementary concepts

  • SARS-CoV-2 variants